Source:http://linkedlifedata.com/resource/pubmed/id/17579182
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2007-9-20
|
pubmed:abstractText |
We performed a randomized trial comparing the use of quantitative DNAemia versus positive antigenemia for starting preemptive antihuman cytomegalovirus (HCMV) therapy in hematopoietic stem-cell transplantation (HSCT) recipients. In the DNAemia arm, antiviral therapy was initiated on reaching a DNAemia cut-off of 10 000 DNA copies/mL of whole blood, whereas in the antigenemia arm, therapy was started in the presence of a positive antigenemia. The aim of the study was to compare the number of patients treated in the 2 arms. On the whole, 178 patients (89 in each arm), receiving unmanipulated HSCT from either a relative or an unrelated donor, completed the study. Although the incidence of HCMV infection was comparable in DNAemia and antigenemia arms (34% vs 42%, respectively, P = .259), the number of patients treated was significantly lower in the DNAemia arm (18% vs 31%, P = .026). No patient developed HCMV disease. The use of a DNAemia cut-off avoids unnecessary antiviral treatment.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2757-60
|
pubmed:dateRevised |
2008-5-13
|
pubmed:meshHeading |
pubmed-meshheading:17579182-Adolescent,
pubmed-meshheading:17579182-Adult,
pubmed-meshheading:17579182-Antigens, Viral,
pubmed-meshheading:17579182-Child,
pubmed-meshheading:17579182-Child, Preschool,
pubmed-meshheading:17579182-Cytomegalovirus,
pubmed-meshheading:17579182-Cytomegalovirus Infections,
pubmed-meshheading:17579182-DNA, Viral,
pubmed-meshheading:17579182-Female,
pubmed-meshheading:17579182-Follow-Up Studies,
pubmed-meshheading:17579182-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17579182-Humans,
pubmed-meshheading:17579182-Infant,
pubmed-meshheading:17579182-Infant, Newborn,
pubmed-meshheading:17579182-Male
|
pubmed:year |
2007
|
pubmed:articleTitle |
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia.
|
pubmed:affiliation |
Servizio di Virologia, Università di Pavia, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|